Category Press Releases

CVS Pharmacy® (NYSE: CVS), a division of CVS Health®, has introduced a new line of journals featuring cover designs by four CVS Health colleagues, inspired by their personal mental health…

SurGenTec, a leader in orthopedic and spine technology, is excited to announce that its proprietary B-MAN Bone Marrow Aspirate Kit has received 510(k) clearance from the U.S. Food and Drug…

Alcon (SIX/NYSE:ALC), a global leader in eye care, announced its financial results for the second quarter and first half of 2024. In Q2 2024, the company achieved sales of $2.5…

Trilliant Health, a top analytics firm in the healthcare sector, has introduced a free version of its Provider Directory application. This user-friendly tool offers a centralized source for precise and…

Alpenglow Biosciences, a pioneer in 3D spatial biology, has recently received contracts from the Advanced Research Projects Agency for Health (ARPA-H) and the National Institutes of Health (NIH). Additionally, the…

Quince Therapeutics, Inc. (Nasdaq: QNCX), a biotechnology company focused on utilizing patients’ own biology to treat rare diseases, has announced the online publication of data from its Phase 3 ATTeST…

Lobe Sciences Ltd (CSE: LOBE, OTCQB: LOBEF) has announced the election of a new board of directors following its annual general meeting. Shareholders elected Dr. Frederick D. Sancilio, Dr. Harry…

Tandem Diabetes Care, Inc. (Nasdaq: TNDM) has provided an update regarding the March 2024 recall of its t:connect mobile app for Apple iOS devices. The recall addresses an issue causing…

Pulse Biosciences, Inc. (Nasdaq: PLSE) has announced that it successfully treated the first two patients in its initial human feasibility study using its innovative Cardiac Surgery System. This study, which…

Apyx Medical Corporation (NASDAQ: APYX), the maker of the Renuvion® helium plasma and radiofrequency platform, has announced a peer-reviewed article in Plastic and Reconstructive Surgery—Global Open. The study compares Renuvion’s…

Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology company specializing in treating primary and metastatic liver cancers, has announced its financial results and business highlights for the second quarter ended…

California University of Science and Medicine (CUSM) has announced a grant from Bank of America to enhance healthcare in rural Inland Empire communities. The funding will support CUSM’s initiative to…